Azenta, Inc. Files 8-K for Financial Reporting
Ticker: AZTA · Form: 8-K · Filed: Jan 30, 2025 · CIK: 933974
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Azenta filed its 8-K on Jan 30, 2025, with financial updates. Nothing major new.
AI Summary
On January 30, 2025, Azenta, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhibits, but does not specify any new material events or transactions.
Why It Matters
This 8-K filing provides an update on Azenta, Inc.'s financial condition and operational results, which is crucial for investors to assess the company's performance and make informed decisions.
Risk Assessment
Risk Level: low — The filing is a routine financial report and does not indicate any significant new risks or material adverse events.
Key Players & Entities
- Azenta, Inc. (company) — Registrant
- 200 Summit Drive, Burlington, MA 01803 (location) — Business Address
- January 30, 2025 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by Azenta, Inc.?
The primary purpose of this 8-K filing is to report on Azenta, Inc.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is January 30, 2025.
What is Azenta, Inc.'s state of incorporation and fiscal year end?
Azenta, Inc. is incorporated in Delaware and its fiscal year ends on September 30.
What was Azenta, Inc. formerly known as?
Azenta, Inc. was formerly known as Brooks Automation, Inc., Brooks Automation Inc, and Brooks-Pri Automation Inc.
What is the business address of Azenta, Inc. as listed in the filing?
The business address of Azenta, Inc. is 200 Summit Drive, 6th Floor, Burlington, MA 01803.
Filing Stats: 1,025 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2025-01-30 16:50:20
Key Financial Figures
- $0.01 — ge on which registered Common Stock , $0.01 par value AZTA The Nasdaq Stock Mark
Filing Documents
- azta20250124_8k.htm (8-K) — 29KB
- ex_770240.htm (EX-99.1) — 404KB
- 0001437749-25-002273.txt ( ) — 588KB
- azta-20250130.xsd (EX-101.SCH) — 3KB
- azta-20250130_def.xml (EX-101.DEF) — 11KB
- azta-20250130_lab.xml (EX-101.LAB) — 15KB
- azta-20250130_pre.xml (EX-101.PRE) — 11KB
- azta20250124_8k_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition As previously disclosed on November 12, 2024, Azenta, Inc. (the "Company") announced that it is pursuing a sale of its B Medical Systems segment, a manufacturer and global distributor of medical refrigeration devices based in Luxembourg. This strategic action is intended to simplify the Company's portfolio and allow management to focus on driving revenue growth and profitability in its core Sample Management Solutions and Multiomics businesses. The decision followed work by the Company's Board of Directors to evaluate strategic, operational and financial opportunities to maximize shareholder value. The Company has concluded that, as of the date of the announcement on November 12, 2024, the B Medical Systems segment met the held-for-sale criteria and qualifies as a discontinued operation under U.S. generally accepted accounting principles. In order to assist investors in understanding the impact of the separation of the B Medical Systems segment on the Company's financial results, the Company is furnishing in Exhibit 99.1 to this Current Report, which exhibit is incorporated herein by reference, revised unaudited financial information for the twelve months ended September 30, 2023, for the three months ended December 31, 2023, for the three and six months ended March 31, 2024, for the three and nine months ended June 30, 2024 and for the three and twelve months ended September 30, 2024 and as of September 30, 2024, recast to reflect the separation of the B Medical Systems segment and its classification as a discontinued operation. Limitation on Incorporation by Reference . The information in Item 2.02 and Exhibit 99.1 to this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits EXHIBIT NUMBER DESCRIPTION 99.1 Azenta, Inc. Revised Financial Information 104 Cover Page Interactive Data File (embedded within the iXBRL (Inline eXtensible Business Reporting Language) document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AZENTA, INC. /s/ Jason W. Joseph Date: January 30, 2025 Jason W. Joseph Senior Vice President, General Counsel and Secretary